Pliant Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLRX and other ETFs, options, and stocks.About PLRX
Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine.
CEOBernard Coulie
CEOBernard Coulie
Employees171
Employees171
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2015
Founded2015
Employees171
Employees171
PLRX Key Statistics
Market cap78.26M
Market cap78.26M
Price-Earnings ratio-0.43
Price-Earnings ratio-0.43
Dividend yield—
Dividend yield—
Average volume2.91M
Average volume2.91M
High today$1.33
High today$1.33
Low today$1.23
Low today$1.23
Open price$1.33
Open price$1.33
Volume1.57M
Volume1.57M
52 Week high$15.00
52 Week high$15.00
52 Week low$1.10
52 Week low$1.10
Stock Snapshot
With a market cap of 78.26M, Pliant Therapeutics(PLRX) trades at $1.24. The stock has a price-to-earnings ratio of -0.43.
As of 2025-12-14, Pliant Therapeutics(PLRX) stock has fluctuated between $1.23 and $1.33. The current price stands at $1.24, placing the stock +1.2% above today's low and -6.8% off the high.
Pliant Therapeutics(PLRX) shares are trading with a volume of 1.57M, against a daily average of 2.91M.
During the past year, Pliant Therapeutics(PLRX) stock moved between $1.10 at its lowest and $15.00 at its peak.
During the past year, Pliant Therapeutics(PLRX) stock moved between $1.10 at its lowest and $15.00 at its peak.
Analyst ratings
83%
of 6 ratingsBuy
0%
Hold
83.3%
Sell
16.7%
People also own
Based on the portfolios of people who own PLRX. This list is generated using Robinhood data, and it’s not a recommendation.